
Abram's provides rapid coagulation diagnostics for improved clinical outcomes in hemostasis disorders.
Abram Scientific was founded with the mission to revolutionize the diagnosis and management of coagulation-related disorders through rapid and precise blood management solutions. Their core product, the CoagCare Platform, offers a portable, low-cost diagnostic solution that delivers full viscoelastic curves and parameter generation in under minutes using minimal blood samples. This platform aims to provide accurate and actionable hemostasis information to improve clinical outcomes, particularly in critical care settings.
Notable affiliated individuals and investors in Abram Scientific include experts in medical diagnostics and healthcare innovation, although specific names are not provided. The company has achieved significant milestones by developing a handheld, wireless meter that is vibration-insensitive and utilizes single-use diagnostic test strips. This innovation has the potential to significantly impact patient care by enabling rapid and precise blood coagulation diagnostics, thereby improving treatment decisions and outcomes in real-time.

Coagulo Medical Technologies
coagulomed.com

iFirst Medical Technologies
ifirstmedtech.com

Proxim Diagnostics
proximdx.com

Exactus

Instadiagnostics

Coagulation Sciences

Perosphere Technologies
perospheretech.com

Amplified Sciences

ThromboVision

Babson Diagnostics
babsondx.com

Semler Scientific

Prompt Diagnostics
prompt-dx.com

FloBio
flobiollc.com

Chemeleon
chemeleon.com

BioAmp diagnostics
bioampdx.com
Companies similar to Abram Scientific include Coagulo Medical Technologies, iFirst Medical Technologies, Proxim Diagnostics and Exactus.
Abram Scientific was founded in 2013.
Abram Scientific's headquarters is located in Menlo Park, CA, US.
Abram Scientific's most recent funding round was for $3.9M (USD) in April 2021.
As of Apr 6, 2021, Abram Scientific has raised a total of $4.3M (USD).
Abram Scientific has 5 employees as of Feb 4, 2024.